Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 72

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 72
---
 shareholder’s vote by providing the original wet ink signed proxy card at the NLS Meeting which explicitly names the registered shareholder or third party as its designated representative. If a shareholder grants a proxy, it may still vote its shares itself if it revokes its proxy before the NLS Meeting. A shareholder may also change its vote by entering a new vote by Internet, submitting a later -datedproxy. With the representation by the independent proxy or a third party, a shareholder has no additional right of physical attendance at the NLS Meeting. Recommendation of the NLS Board to Shareholders The NLS Board has determined that the Merger and the other Proposals to be presented at the NLS Meeting are fair to and in the best interest of NLS’s shareholders and unanimously recommends that its shareholders vote •“FOR” Proposal No. 1 to approve the Merger Agreement. •“FOR” Proposal No. 2 to approve the ordinary share capital increase with contribution of the Kadimastem shares to implement the Merger. •“FOR” Proposal No. 3 to approve the ordinary share capital increase regarding the issuance of preferred shares. •“FOR” Proposal No. 4 to approve the reinstatement of the capital band. •“FOR” Proposal No. 5 to approve the conditional share capital for employee and advisory options. •“FOR” Proposal No. 6 to approve the conditional share capital for shareholders’ options. •“FOR” Proposal No. 7 to approve the name change of NLS. •“FOR” Proposal No. 8 to approve the election of the new members to the NLS Board. •“FOR” Proposal No. 9 to approve the election of members of the Compensation, Nomination and Governance Committee. •“FOR” Proposal No. 10 to approve the composition of the new senior management following the Merger. •“FOR” Proposal No. 11.1 to approve the compensation for the members of the NLS Board. •“FOR” Proposal No. 11.2 to approve compensation for the executive officers. •“FOR” Proposal No. 12 to approve the CVR Agreement. •“FOR” Proposal No. 13 to approve the conversion of outstanding options and RSUs issued by Kadimastem. Reasons for the Merger (Page 99) In reaching its decision to approve the Merger Agreement and the transactions contemplated by the Merger Agreement, the NLS Board took into account information presented during the process and considered the following factors that it viewed